Nano-lc-esi-ms/ms

Show results for

Proteomics (911)
Unknown (67)
Metabolomics (2)
Genomics (2)
Other (1)

Organisms

Allexis (902)
Arabidopsis thaliana (902)
Homo sapiens (902)
Listeria monocytogenes (902)
Mus musculus (902)
Rattus norvegicus (902)
Saccharomyces cerevisiae (902)
Schizosaccharomyces pombe (902)
Shigella (902)
Shigella flexneri (902)
Staphylococcus aureus (902)
Bos taurus (901)
Callinectes sapidus (901)
Drosophila melanogaster (901)
Entamoeba histolytica (901)
Entamoeba histolytica HM-1:IMSS-A (901)
Escherichia coli (901)
Leishmania major strain Friedlin (901)
Medicago truncatula (901)
Meleagris gallopavo (901)
Methylohalobius crimeensis 10Ki (901)
Mycobacterium tuberculosis (901)
Oryza sativa Indica Group (901)
Pseudomonas fluorescens WH6 (901)
Sinorhizobium meliloti BL225C (901)
Solanum tuberosum (901)
Sus scrofa domesticus (901)
Trypanosoma brucei (901)
Homo sapiens (2)
Saccharomyces cerevisiae (1)

Organisms

Xanthomonas campestris (1)
Danio rerio (1)

Repository

pride (902)
MassIVE (4)
jPOST (2)
MetaboLights (2)
PeptideAtlas (2)
ENA (2)
GPMDB (1)
PanoramaPublic (1)

Tissue

Cell culture (199)
Epithelial cell (49)
Brain (45)
Plant cell (39)
Permanent cell line cell (34)
Leaf (30)
Blood plasma (29)
Liver (28)
Blood (17)
Cell suspension culture (16)
Heart (15)
Colon (14)
Whole body (13)
Blood serum (12)
Urine (12)
Blood cell (11)
Kidney (11)
Lung (10)
Photosynthetic cell (10)
Hepatocyte (9)
Prokaryotic cell (9)
Root (9)
Saliva (9)
T cell (8)
Cerebrospinal fluid (7)
Fibroblast (7)
Rosette (7)
Testis (7)
Macrophage (6)
Placenta (6)

Disease

Breast cancer (26)
Disease free (14)
Colon cancer (12)
Cardiovascular system disease (7)
Malignant neoplasm of ovary (7)
Alzheimer's disease (6)
Cervix carcinoma (6)
Obesity (6)
Brain cancer (5)
Brain glioblastoma multiforme (5)
Parkinson's disease (5)
Prostate adenocarcinoma (5)
Severe acute respiratory syndrome (5)
Acute leukemia (4)
COVID-19 (4)
Chronic lymphocytic leukemia (4)
Hepatocellular carcinoma (4)
Prostate cancer (4)
Tuberculosis (4)
Chagas disease (3)
Cholangiocarcinoma (3)
Cystic fibrosis (3)
Giardiasis (3)
Glioblastoma (3)
Gonorrhea (3)
Lung cancer (3)
Lymphoma (3)
Non-small cell lung carcinoma (3)
Osteoarthritis (3)
Not Available (1)

Technology Type

Mass Spectrometry (902)
Shotgun proteomics (481)
Bottom-up proteomics (167)
Data-dependent acquisition (90)
Affinity purification coupled with mass spectrometry proteomics (85)
Gel-based experiment (73)
Data-independent acquisition (45)
Top-down proteomics (31)
SWATH MS (27)
Chemical cross-linking coupled with mass spectrometry proteomics (22)
SRM/MRM (16)
HDMSE (10)
All-ion fragmentation (8)
MSE (8)
DiaPASEF (5)
Mass spectrometry imaging (5)
Mass spectrometry (2)
Affinity proteomics (2)
Glycoproteomics (1)
Metaproteomics (1)
Proteogenomics (1)
RNA mass spectrometry (1)

Instrument Platform

Impact (2)
LTQ Orbitrap Velos (2)
Instrument (1)
LTQ XL ETD (1)
QExactive (1)
Matrix-assisted laser desorption-ionisation imaging MS - (1)
Direct infusion MS - positive (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
LTQ-FT Ultra (1)
Thermo Scientific LTQ (1)

Publication Date

2025 (126)
2026 (106)
2024 (106)
2023 (102)
2022 (101)
2021 (85)
2020 (68)
2018 (57)
2017 (47)
2019 (44)
2016 (28)
2014 (19)
2015 (19)
2013 (3)
2012 (1)

UNIPROT ID/AC

A0A4W9 (2)
A1L347 (2)
A2A543 (2)
A2A7S7 (2)
A2ACL9 (2)
A2AP31 (2)
A2AQL0 (2)
A2AQR0 (2)
A2ASZ8-4 (2)
A2ATZ8 (2)
A2AWI7 (2)
A2RS22 (2)
A2RSV8 (2)
A3KML5 (2)
A3R3Q8 (2)
A3R404 (2)
A6ZI44 (2)
B0V2N1 (2)
B1ATI0 (2)
B1ATS4 (2)
B1AWD8 (2)
B1AWN6 (2)
B2MWM9 (2)
B2RQX4 (2)
B2RQY8 (2)
B2RRX1 (2)
B2RRX2 (2)
B2RS41 (2)
B2RSH2 (2)
B2RSY3 (2)

ENSEMBL ID

ENSMUSP00000141097 (2)
ENSMUSG00000072849 (1)
ENSMUSG00000098557 (1)

CHEBI ID

CHEBI:87239 (1)
CHEBI:85682 (1)
CHEBI:88057 (1)
CHEBI:134574 (1)
CHEBI:137836 (1)
CHEBI:134572 (1)
CHEBI:142374 (1)
CHEBI:167289 (1)
CHEBI:167288 (1)
CHEBI:167293 (1)
CHEBI:167291 (1)
CHEBI:167292 (1)
CHEBI:142372 (1)
CHEBI:167290 (1)
CHEBI:136199 (1)
CHEBI:136202 (1)
CHEBI:140496 (1)
CHEBI:167287 (1)
CHEBI:167285 (1)
CHEBI:167286 (1)
CHEBI:167283 (1)
CHEBI:167284 (1)
CHEBI:140354 (1)
CHEBI:138905 (1)
CHEBI:131536 (1)
CHEBI:131540 (1)
CHEBI:132785 (1)
CHEBI:167035 (1)
CHEBI:155818 (1)
CHEBI:132780 (1)

Metabolite Name

Cholesterol (1)

First Public Date

2023 (1)
2022 (1)

Modification

15.994915 (3)
4-tetrahydrothiazine-3-carboxylic acid (3)
Not available (2)
+3amu) (1)
-17.026549 (1)
32.056407 (1)
4 (1)
42.010565 (1)
45.029395 (1)
4x(15)N labeled L-arginine (1)
57.021464 (1)
N6-dimethyl-L-lysine (1)

Release Date

2021 (9)
2019 (8)
2020 (6)
2014 (6)
2025 (5)
2012 (5)
2013 (4)
2011 (4)
2023 (3)
2016 (3)
2022 (2)
2018 (2)
2017 (2)
2015 (2)
2010 (2)
2009 (2)
2024 (1)
2008 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (20)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg im Breisgau, Germany (16)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (11)
Biomolecular characterization unit, Center for Sustainable Resource Science, RIKEN (6)
LMU Munich Plant Biochemistry and Physiology, Germany (6)
Chair of Biochemistry II, Theodor Boveri-Institute, Biocenter, University of Würzburg, Würzburg, Germany (5)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104 Freiburg im Breisgau, Germany (5)
Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (5)
Centre for Cancer Cell & Molecular Biology Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ U.K. (4)
Department of Cardiovascular Medicine, Center for Circadian Metabolism and Cardiovascular Disease, Southwest Hospital, Army Medical University; Chongqing, China. (4)
MSBioLMU Großhaderner Str. 2-4 82152 Planegg-Martinsried (4)
Professor (4)
Texas Tech University (4)
Crick-GSK LinkLabs, UK (3)
Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain (3)
Department of Chemistry and Biomolecular Sciences, University of Ottawa, Canada (3)
Department of Pharmaceutical Chemistry and Bioanalytics Institute of Pharmacy Martin Luther University Halle-Wittenberg Halle (Saale), Germany (3)
Dept. Oncology Pathology, Karolinska Institutet, and Scilifelab, Stockholm, Sweden (3)
Evolutionary and translational venomics Lab, Instituto de Biomedicina de Valencia, CSIC (3)
Head of Laboratory of Neuro-Oncology, Neurology, Clinical & Cancer Proteomics (3)
State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, Shanghai 200438, China (3)
The University of Melbourne (3)
Universität Greifswald Institut für Pharmazie, AG Pharmazeutische Biotechnologie Greifswald, Germany (3)
de Duve Institute UCLouvain and WELBIO (3)
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500 Selangor Darul Ehsan, Malaysia. (2)
Assistant Professor, Evolutionary Venomics Lab, Center for Ecological Sciences, Indian Institute of Science, Bangalore, India (2)
Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Australia (2)
Biology department, Washington University in Saint Louis, Saint Louis, MO, USA (2)
Centre for Ocular Regeneration (CORE), Prof. Brien Holden Eye Research Centre (BHERC), L V Prasad Eye Institute, Hyderabad, Telangana, India (2)
Centre for Proteome Research, University of Liverpool (2)

Previous page
1 / 99
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 99
Next page

Sort by:

Relevance

Page size

Immunoprecipitation of PTEN coupled Nano-LC−ESI-MS/MS

Nuclear localization of PTEN is essential for its tumor suppressive role, and loss of nuclear PTEN is more prominent than cytoplasmic PTEN in many kinds of cancers. However, nuclear PTEN-specific regulatory mechanisms were rarely reported. Based on the finding that nuclear PTEN is more unstable than...

ORGANISM(S): Homo sapiens (Human)

2020-04-22 | PXD017983 | Pride

A shotgun proteomics reference map for the alkali-sensitive covalently-linked proteins of the cell wall of A. fumigatus during specific stages of early fungal development (dormant conidia, isotropically expanding conidia, early germ tube emergence and young hyphae).

Four different developmental time points representing the Afu development from dormant conidia into young hyphae (0h, 4h, 6h, 8h) were chosen. Cell walls of the Afu samples were extracted using denaturing methods followed by isolation of solubilized proteins. Samples were processed using filter aide...

ORGANISM(S): Aspergillus fumigatus Af293

2016-12-20 | PRD000567 | Pride

Improved Sensitivity in Low-Input Proteomics using Micro-Pillar Array-based Chromatography

Capitalizing on the massive increase in sample concentrations which are produced by extremely low elution volumes, nano-LC-ESI-MS/MS is currently the most sensitive analytical technology for the comprehensive characterization of complex protein samples. However, despite tremendous technological impr...

ORGANISM(S): Homo sapiens (Human)

2019-10-23 | PXD014124 | Pride

Nano-lc-esi-ms/ms nano-flow hplc hela cell digest

Pericardial fluid proteomic label-free quantification of differentially expressed proteins in ischemic heart disease patients with systolic dysfunction by nano-LC-ESI-MS/MS analysis.

Not available

S-EPMC8691035 | biostudies-literature

Insulin stimulated MCF7 breast cancer cells

Proteome profile of MCF7 breast cancer cells stimulated with insulin and analyzed by nano-LC-ESI-MS/MS.

ORGANISM(S): Homo sapiens (Human)

2016-11-30 | PXD004051 | Pride

Ms/ms 2d-scx/rplc Breast cancer Cell line

Characterization of ACE inhibitory peptides from Mactra veneriformis hydrolysate by nano-liquid chromatography electrospray ionization mass spectrometry (Nano-LC-ESI-MS) and molecular docking.